Bordetella pertussisfimbriae are effective carrier proteins inNeisseria meningitidisserogroup C conjugate vaccines
نویسندگان
چکیده
منابع مشابه
Bordetella pertussis fimbriae are effective carrier proteins in Neisseria meningitidis serogroup C conjugate vaccines.
Serogroup C meningococcal conjugate vaccines generally use diphtheria or tetanus toxoids as the protein carriers. The use of alternative carrier proteins may allow multivalent conjugate vaccines to be formulated into a single injection and circumvent potential problems of immune suppression in primed individuals. Bordetella pertussis fimbriae were assessed as carrier proteins for Neisseria meni...
متن کاملMeningococcal group C conjugate vaccines
In November 1999 the Department of Health introduced a national vaccination programme using newly licensed meningococcal serogroup C conjugate vaccines (MenC). In the largest national mass vaccination campaign ever undertaken in the UK, all people under the age of 18 years are being oVered vaccination: three doses for infants as part of the primary vaccination schedule at 2, 3, and 4 months of ...
متن کاملMeningococcal group C conjugate vaccines
In November 1999 the Department of Health introduced a national vaccination programme using newly licensed meningococcal serogroup C conjugate vaccines (MenC). In the largest national mass vaccination campaign ever undertaken in the UK, all people under the age of 18 years are being oVered vaccination: three doses for infants as part of the primary vaccination schedule at 2, 3, and 4 months of ...
متن کاملMeningococcal group C conjugate vaccines
In November 1999 the Department of Health introduced a national vaccination programme using newly licensed meningococcal serogroup C conjugate vaccines (MenC). In the largest national mass vaccination campaign ever undertaken in the UK, all people under the age of 18 years are being oVered vaccination: three doses for infants as part of the primary vaccination schedule at 2, 3, and 4 months of ...
متن کاملMeningococcal group C conjugate vaccines
In November 1999 the Department of Health introduced a national vaccination programme using newly licensed meningococcal serogroup C conjugate vaccines (MenC). In the largest national mass vaccination campaign ever undertaken in the UK, all people under the age of 18 years are being oVered vaccination: three doses for infants as part of the primary vaccination schedule at 2, 3, and 4 months of ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: FEMS Immunology & Medical Microbiology
سال: 2001
ISSN: 0928-8244,1574-695X
DOI: 10.1111/j.1574-695x.2001.tb00512.x